ADCT vs BK · rev $40.1M vs P/E 17, $94.14B cap
ADC Therapeutics SA (ADCT) versus The Bank of New York Mellon Corporation (BK) — a side-by-side from cached financials, not a winner call.
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Latest reported ADCT revenue for 2026-06-30 was $40.1M. Net income was -$49.5M. Revenue was up 92.3% from 2026-03-31 to 2026-06-30. ADCT currently screens at market cap $141.2M.
BK does not have a complete income-statement cache yet.
ADCT currently screens at market cap $141.2M. BK currently screens at market cap $94.14B and trailing P/E 17.0.
Not investment advice. Open the ADCT and BK stock pages for the full models.
Not investment advice.